These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

610 related items for PubMed ID: 18325087

  • 1. Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study.
    Naranjo A, Sokka T, Descalzo MA, Calvo-Alén J, Hørslev-Petersen K, Luukkainen RK, Combe B, Burmester GR, Devlin J, Ferraccioli G, Morelli A, Hoekstra M, Majdan M, Sadkiewicz S, Belmonte M, Holmqvist AC, Choy E, Tunc R, Dimic A, Bergman M, Toloza S, Pincus T, QUEST-RA Group.
    Arthritis Res Ther; 2008; 10(2):R30. PubMed ID: 18325087
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Prevalence of cardiovascular diseases and traditional cardiovascular risk factors in patients with rheumatoid arthritis: a real-life evidence from BioSTAR nationwide registry.
    Duruöz MT, Ataman Ş, Bodur H, Çay HF, Melikoğlu MA, Akgül Ö, Çapkın E, Gürer G, Çevik R, Göğüş FN, Kamanlı A, Yurdakul FG, Yağcı İ, Rezvani A, Altan L.
    Rheumatol Int; 2024 Feb; 44(2):291-301. PubMed ID: 38157014
    [Abstract] [Full Text] [Related]

  • 5. Cardiovascular events in early RA are a result of inflammatory burden and traditional risk factors: a five year prospective study.
    Innala L, Möller B, Ljung L, Magnusson S, Smedby T, Södergren A, Öhman ML, Rantapää-Dahlqvist S, Wållberg-Jonsson S.
    Arthritis Res Ther; 2011 Aug 15; 13(4):R131. PubMed ID: 21843325
    [Abstract] [Full Text] [Related]

  • 6. Cardiovascular risk estimation with 5 different algorithms before and after 5 years of bDMARD treatment in rheumatoid arthritis.
    Cacciapaglia F, Fornaro M, Venerito V, Perniola S, Urso L, Iannone F.
    Eur J Clin Invest; 2020 Dec 15; 50(12):e13343. PubMed ID: 32654116
    [Abstract] [Full Text] [Related]

  • 7. Risk of diabetes mellitus associated with disease-modifying antirheumatic drugs and statins in rheumatoid arthritis.
    Ozen G, Pedro S, Holmqvist ME, Avery M, Wolfe F, Michaud K.
    Ann Rheum Dis; 2017 May 15; 76(5):848-854. PubMed ID: 27836820
    [Abstract] [Full Text] [Related]

  • 8. Disease activity in rheumatoid arthritis and the risk of cardiovascular events.
    Solomon DH, Reed GW, Kremer JM, Curtis JR, Farkouh ME, Harrold LR, Hochberg MC, Tsao P, Greenberg JD.
    Arthritis Rheumatol; 2015 Jun 15; 67(6):1449-55. PubMed ID: 25776112
    [Abstract] [Full Text] [Related]

  • 9. Biologics and cardiovascular events in inflammatory arthritis: a prospective national cohort study.
    Lee JL, Sinnathurai P, Buchbinder R, Hill C, Lassere M, March L.
    Arthritis Res Ther; 2018 Aug 07; 20(1):171. PubMed ID: 30086795
    [Abstract] [Full Text] [Related]

  • 10. The impact of traditional cardiovascular risk factors on cardiovascular outcomes in patients with rheumatoid arthritis: a systematic review and meta-analysis.
    Baghdadi LR, Woodman RJ, Shanahan EM, Mangoni AA.
    PLoS One; 2015 Aug 07; 10(2):e0117952. PubMed ID: 25689371
    [Abstract] [Full Text] [Related]

  • 11. Immunosuppressive medications and hospitalization for cardiovascular events in patients with rheumatoid arthritis.
    Solomon DH, Avorn J, Katz JN, Weinblatt ME, Setoguchi S, Levin R, Schneeweiss S.
    Arthritis Rheum; 2006 Dec 07; 54(12):3790-8. PubMed ID: 17136752
    [Abstract] [Full Text] [Related]

  • 12. Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients?
    Gonzalez A, Maradit Kremers H, Crowson CS, Ballman KV, Roger VL, Jacobsen SJ, O'Fallon WM, Gabriel SE.
    Ann Rheum Dis; 2008 Jan 07; 67(1):64-9. PubMed ID: 17517756
    [Abstract] [Full Text] [Related]

  • 13. Cardiovascular risk in rheumatoid arthritis: comparing TNF-α blockade with nonbiologic DMARDs.
    Solomon DH, Curtis JR, Saag KG, Lii J, Chen L, Harrold LR, Herrinton LJ, Graham DJ, Kowal MK, Kuriya B, Liu L, Griffin MR, Lewis JD, Rassen JA.
    Am J Med; 2013 Aug 07; 126(8):730.e9-730.e17. PubMed ID: 23885678
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Derivation and internal validation of an expanded cardiovascular risk prediction score for rheumatoid arthritis: a Consortium of Rheumatology Researchers of North America Registry Study.
    Solomon DH, Greenberg J, Curtis JR, Liu M, Farkouh ME, Tsao P, Kremer JM, Etzel CJ.
    Arthritis Rheumatol; 2015 May 07; 67(8):1995-2003. PubMed ID: 25989470
    [Abstract] [Full Text] [Related]

  • 16. Biologic Agents Reduce Cardiovascular Events in Rheumatoid Arthritis Not Responsive to Tumour Necrosis Factor Inhibitors: A National Cohort Study.
    Hsieh MJ, Lee CH, Tsai ML, Kao CF, Lan WC, Huang YT, Tseng WY, Wen MS, Chang SH.
    Can J Cardiol; 2020 Nov 07; 36(11):1739-1746. PubMed ID: 32603700
    [Abstract] [Full Text] [Related]

  • 17. Subcutaneous nodules are associated with cardiovascular events in patients with rheumatoid arthritis: results from a large US registry.
    Kaushik P, Solomon DH, Greenberg JD, Anderson JT, Reed G, Pala O, Sumbul-Yuksel B, Kadam P, Kremer JM, CORRONA investigators.
    Clin Rheumatol; 2015 Oct 07; 34(10):1697-704. PubMed ID: 26242470
    [Abstract] [Full Text] [Related]

  • 18. Cardiovascular disease in rheumatoid arthritis: medications and risk factors in China.
    Li C, Wang XR, Ji HJ, Zhang XY, Li XF, Wang LZ, Wang CH, Wang YF, Yang R, Wang GC, Lu X, Zhu P, Chen LN, Jin HT, Liu JT, Liu XY, Sun L, Chen HY, Wei P, Wang JX, Cui LF, Shu R, Liu BL, Zhang ZL, Li GT, Li ZB, Yang J, Li JF, Jia B, Zhang FX, Tao JM, Han SL, Lin JY, Wei MQ, Liu XM, Ke D, Hu SX, Ye C, Yang XY, Li H, Huang CB, Gao M, Lai B, Li XF, Song LJ, Wang Y, Wang XY, Tang YD, Su Y, Mu R, Li ZG.
    Clin Rheumatol; 2017 May 07; 36(5):1023-1029. PubMed ID: 28342151
    [Abstract] [Full Text] [Related]

  • 19. Short-term dose and duration-dependent glucocorticoid risk for cardiovascular events in glucocorticoid-naive patients with rheumatoid arthritis.
    Ocon AJ, Reed G, Pappas DA, Curtis JR, Kremer JM.
    Ann Rheum Dis; 2021 Dec 07; 80(12):1522-1529. PubMed ID: 34215644
    [Abstract] [Full Text] [Related]

  • 20. Rheumatoid arthritis, as a clinical disease, but not rheumatoid arthritis-associated autoimmunity, is linked to cardiovascular events.
    Gouze H, Aegerter P, Said-Nahal R, Zins M, Goldberg M, Morelle G, Schett G, Breban M, D'Agostino MA.
    Arthritis Res Ther; 2022 Feb 24; 24(1):56. PubMed ID: 35209936
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.